Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification
Open Access
- 17 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Research
- Vol. 9 (1), 1-12
- https://doi.org/10.1038/s41413-021-00140-6
Abstract
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress inflammation but do not effectively halt the progression of spine fusion in AS patients. Here we report that the autoimmune inflammation of AS generates a microenvironment that promotes chondrogenesis in spine ligaments as the process of spine fusion. Chondrocyte differentiation was observed in the ligaments of patients with early-stage AS, and cartilage formation was followed by calcification. Moreover, a large number of giant osteoclasts were found in the inflammatory environment of ligaments and on bony surfaces of calcified cartilage. Resorption activity by these giant osteoclasts generated marrow with high levels of active TGF-β, which induced new bone formation in the ligaments. Notably, no Osterix+ osteoprogenitors were found in osteoclast resorption areas, indicating uncoupled bone resorption and formation. Even at the late and maturation stages, the uncoupled osteoclast resorption in bony interspinous ligament activates TGF-β to induce the progression of ossification in AS patients. Osteoclast resorption of calcified cartilage-initiated ossification in the progression of AS is a similar pathologic process of acquired heterotopic ossification (HO). Our finding of cartilage formation in the ligaments of AS patients revealed that the pathogenesis of spinal fusion is a process of HO and explained why anti-inflammatory treatments do not slow ankylosing once there is new bone formation in spinal soft tissues. Thus, inhibition of HO formation, such as osteoclast activity, cartilage formation, or TGF-β activity could be a potential therapy for AS.Keywords
Funding Information
- FOX
This publication has 61 references indexed in Scilit:
- Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritisNature Medicine, 2013
- Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healingInjury, 2011
- Conversion of vascular endothelial cells into multipotent stem-like cellsNature Medicine, 2010
- TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formationNature Medicine, 2009
- Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2008
- Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanerceptArthritis & Rheumatism, 2008
- The relationship between inflammation and new bone formation in patients with ankylosing spondylitisArthritis Research & Therapy, 2008
- TGF-β and osteoarthritisOsteoarthritis and Cartilage, 2007
- A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: Comment on the article by Maksymowych et alArthritis & Rheumatism, 2003
- Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans ProgressivaThe New England Journal of Medicine, 1996